|Netarsudil||Rho kinase inhibitor|
|Latanoprost||Prostaglandin F2α analogue|
|Trade names||Rocklatan, Roclanda|
|AHFS/Drugs.com||Professional Drug Facts|
Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. It contains netarsudil mesylate and latanoprost. It is applied as eye drops to the eyes.
The most common side effects include conjunctival hyperaemia (red eye), pain at the site where the medicine was applied, cornea verticillata (deposits in the cornea, the transparent layer in front of the eye that covers the pupil and iris), pruritus (itching of the eye), erythema (reddening) and discomfort in the eye, increased lacrimation (watery eyes), and conjunctival haemorrhage (bleeding in the surface layer of the eye).
- "Rocklatan- netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% solution/ drops". DailyMed. 10 March 2020. Retrieved 2 June 2020.
- "Roclanda EPAR". European Medicines Agency (EMA). 9 November 2020. Retrieved 22 January 2021. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- "Drug Approval Package: Rocklatan Ophthalmic Solution". U.S. Food and Drug Administration (FDA). 20 November 2019. Retrieved 2 June 2020.
- "Latanoprost mixture with netarsudil". Drug Information Portal. U.S. National Library of Medicine.